Please wait while the formulary information is being retrieved.
ALBUTEROL SULFATE (ALBUTEROL SULFATE)
- Bronchospastic pulmonary disease
- Acute asthma attack
- Bronchospasm prevention
- Exercise-induced bronchospasm prevention
- Albuterol Sulfate Syrup
- Albuterol Sulfate Solution For Nebulization
- Albuterol Sulfate Oral Syrup
- Albuterol Sulfate Neb Solution
- By Indication
2 mg/5 mL oral syrup
- 5 milliliters (2 mg) by oral route 3 times per day
0.63 mg/3 mL solution for nebulization
- Dosage information is not available
1.25 mg/3 mL solution for nebulization
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3-4 times daily
2.5 mg/3 mL (0.083 %) solution for nebulization
- Inhale 3 milliliters (2.5 mg) by nebulization route 3 times per day
concentrate 2.5 mg/0.5 mL solution for nebulization
- Inhale 0.5 milliliter (2.5 mg) by nebulization route 3 times per day
concentrate 5 mg/mL(0.5 %) solution for nebulization
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3-4 times daily
2 mg/5 mL oral syrup
- 5 milliliters (2 mg) by oral route 3 times per day
0.63 mg/3 mL solution for nebulization
- Dosage information is not available
1.25 mg/3 mL solution for nebulization
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3-4 times daily
2.5 mg/3 mL (0.083 %) solution for nebulization
- Inhale 3 milliliters (2.5 mg) by nebulization route 3 times per day
concentrate 2.5 mg/0.5 mL solution for nebulization
- Inhale 0.5 milliliter (2.5 mg) by nebulization route 3 times per day
concentrate 5 mg/mL(0.5 %) solution for nebulization
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3-4 times daily
Acute asthma attack
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3 times per day
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 4 times per day
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 3 milliliters (2.5 mg) by nebulization route 3 times per day
- Inhale 3 milliliters (2.5 mg) by nebulization route every 8 hours
- Inhale 3 milliliters (2.5 mg) by nebulization route 4 times per day
- Inhale 3 milliliters (2.5 mg) by nebulization route every 6 hours
- Inhale 3 milliliters (2.5 mg) by nebulization route 3 times per day as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route 4 times per day as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route every 8 hours as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route every 6 hours as needed
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 4 times per day
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 3 times per day
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3 times per day
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 4 times per day
Bronchospasm prevention
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3 times per day
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 4 times per day
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 3 milliliters (2.5 mg) by nebulization route 3 times per day
- Inhale 3 milliliters (2.5 mg) by nebulization route every 8 hours
- Inhale 3 milliliters (2.5 mg) by nebulization route 4 times per day
- Inhale 3 milliliters (2.5 mg) by nebulization route every 6 hours
- Inhale 3 milliliters (2.5 mg) by nebulization route 3 times per day as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route 4 times per day as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route every 8 hours as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route every 6 hours as needed
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 4 times per day
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 3 times per day
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3 times per day
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 4 times per day
Bronchospastic pulmonary disease
- 5 milliliters (2 mg) by oral route 3 times per day
- 5 milliliters (2 mg) by oral route 4 times per day
- 5 milliliters (2 mg) by oral route every 6 hours
- 5 milliliters (2 mg) by oral route every 8 hours
- 10 milliliters (4 mg) by oral route every 8 hours
- 10 milliliters (4 mg) by oral route 3 times per day
- 10 milliliters (4 mg) by oral route 4 times per day
- 10 milliliters (4 mg) by oral route every 6 hours
- 20 milliliters (8 mg) by oral route 4 times per day
- 20 milliliters (8 mg) by oral route 3 times per day
- 20 milliliters (8 mg) by oral route every 8 hours
- 20 milliliters (8 mg) by oral route every 6 hours
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3 times per day
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 4 times per day
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 3 milliliters (2.5 mg) by nebulization route 3 times per day
- Inhale 3 milliliters (2.5 mg) by nebulization route every 8 hours
- Inhale 3 milliliters (2.5 mg) by nebulization route 4 times per day
- Inhale 3 milliliters (2.5 mg) by nebulization route every 6 hours
- Inhale 3 milliliters (2.5 mg) by nebulization route 3 times per day as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route 4 times per day as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route every 8 hours as needed
- Inhale 3 milliliters (2.5 mg) by nebulization route every 6 hours as needed
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 4 times per day
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 3 times per day
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3 times per day
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 4 times per day
Exercise-induced bronchospasm prevention
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3 times per day
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 4 times per day
- Inhale 3 milliliters (1.25 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 4 times per day
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 3 times per day
- Inhale 6 milliliters (2.5 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3-4 times daily
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 3 times per day
- Inhale 0.5 milliliter (2.5 mg) via nebulizer by inhalation route 4 times per day
- None
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- sevoflurane
- Sojourn
- Terrell
- Ultane
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Cardiac arrhythmia
- Chronic myocardial ischemia
- Congenital long QT syndrome
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
- Hypokalemia
- Ketoacidosis
- Metabolic acidosis
- Myocardial ischemia
- Prolonged QT interval
- Seizure disorder
ALBUTEROL SULFATE (ALBUTEROL SULFATE)
- Bronchospastic pulmonary disease
- Acute asthma attack
- Bronchospasm prevention
- Exercise-induced bronchospasm prevention
- None
- Nausea
- Nervousness
- Rhinitis
- Tachycardia
- Tremor
- Upper respiratory infection
- Vomiting
More Frequent
Severe
Less Severe
- Diabetes mellitus
- Ataxia
- Back pain
- Bronchial irritation
- Chills
- Cough
- Cramps in legs
- Depression
- Dizziness
- Drowsy
- Dry throat
- Dysgeusia
- Dyspepsia
- Edema
- Epistaxis
- Eructation
- Excitement
- Fever
- Flatulence
- Flushing
- General weakness
- Headache disorder
- Hyperhidrosis
- Hyperkinesis
- Hypertension
- Increased appetite
- Insomnia
- Migraine
- Mouth irritation
- Muscle spasm
- Palpitations
- Sore throat
- Symptoms of anxiety
- Tachycardia
- Tinnitus
- Urinary tract infection
- Voice change
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal ECG
- Anaphylaxis
- Angina
- Angioedema
- Cardiac arrhythmia
- Chest pain
- Erythema multiforme
- Metabolic acidosis
- Myocardial ischemia
- Paradoxical bronchospasm
- Pharyngeal edema
- ST segment changes
- Stevens-johnson syndrome
- Urticaria
Less Severe
- Anorexia
- Hyperglycemia
- Pallor
- Palpitations
- Pharyngitis
- Skin rash
- Urticaria
- Vertigo
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Albuterol (Inhalation_Solution)
Safety and efficacy not established age < 2 years.
- 1 Day – 2 Years
- Safety and efficacy not established age < 2 years.
Albuterol
- Severity Level:
2
- Additional Notes: Poorly controlled asthma in pregnant pts assoc w/preeclampsia & low birth wt
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Albuterol
Observe for tremors & excitement especially with oral use.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Observe for tremors & excitement especially with oral use. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Albuterol (aerosol Inhal)
Cardiovascular-Use caution in severe cardiovascular diseases, particularly coronary insufficiency, since beta-agonists increase heart rate and blood pressure. Endocrine-Use caution in poorly controlled hyperthyroidism or diabetes.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | Y | N | N | Y |
BEERS: N HEDIS: N STOPP: N
Albuterol (oral, Inj)
Cardiovascular-Use caution in severe cardiovascular diseases, particularly coronary insufficiency, since beta-agonists increase heart rate and blood pressure. Endocrine-Use caution in poorly controlled hyperthyroidism or diabetes.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | Y | N | N | Y |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Acute asthma attack | |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J98.01 | Acute bronchospasm |
| Bronchospasm prevention | |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.990 | Exercise induced bronchospasm |
| J45.998 | Other asthma |
| Bronchospastic pulmonary disease | |
| J44.1 | Chronic obstructive pulmonary disease with (acute) exacerbation |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.99 | Other asthma |
| J45.990 | Exercise induced bronchospasm |
| J45.998 | Other asthma |
| Exercise-induced bronchospasm prevention | |
| J45.990 | Exercise induced bronchospasm |
| 0-9 | A-Z |
|---|---|
| J44.1 | Chronic obstructive pulmonary disease with (acute) exacerbation |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J45.902 | Unspecified asthma with status asthmaticus |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.99 | Other asthma |
| J45.990 | Exercise induced bronchospasm |
| J45.990 | Exercise induced bronchospasm |
| J45.990 | Exercise induced bronchospasm |
| J45.998 | Other asthma |
| J45.998 | Other asthma |
| J98.01 | Acute bronchospasm |
Formulary Reference Tool